Showing 2892 results
-
Press release /Phase III V-MONO study met its primary endpoints, demonstrating superiority of Leqvio (inclisiran) monotherapy vs both placebo and ezetimibe in LDL-C reduction1 Results add to growing body of…
-
Ad hoc release /Ad hoc announcement pursuant to Art. 53 LR Fabhalta achieved a 44% proteinuria reduction from baseline in Phase III APPLAUSE-IgAN interim analysis, compared with 9% in placebo arm,…
-
Press release /Priority Review based on ASC4FIRST Phase III study with Scemblix® data first to show significantly improved molecular response and a favorable safety and tolerability profile compared to standard of…
-
Event /During Eurovision week, the Novartis Campus and the Novartis Pavillon will become a cultural hub, offering free public access, engaging experiences, and inspiring…
-
Event /As Eurovision excitement builds, one of Basel’s most iconic forms of transport is getting a musical makeover. Starting March 31, 2025, the Eurovision tram has hit the…
-
Event /On Saturday, May 17, 2025, as Basel hosts the Eurovision Song Contest, we invite you to Arena plus – an extraordinary public viewing event at St. Jakob-Park,…
-
Event /As part of our Eurovision celebration in Basel, Feel the Beat invites people with and without hearing impairments to come together on one dance floor and experience…
-
Event /As part of our Eurovision partnership and long-standing connection to Basel, Novartis is proud to gift the city the BASEL bench – a lasting symbol of creativity and…
-
Event /As part of our Eurovision celebration, we’ve partnered with Superar Suisse to launch Empowering kids through music – an initiative that gives children and young…
-
Statement /